ZYXI - Zynex receives FDA clearance for CM-1600 fluid monitor
2023-06-20 14:03:58 ET
Medical device maker Zynex ( NASDAQ: ZYXI ) said that it has received clearance from the US Food and Drug Administration for its blood and fluid volume monitoring device CM-1600.
The company said the device, which is non-invasive and wireless, is intended for use in a hospital setting. It added that it intends to seek FDA approval for a laser-based pulse oximeter device in Q4.
More on Zynex:
Zynex spikes on plans for share buybacks
Zynex ditches secondary offering of 2M shares but will pursue $50M notes offering
Zynex: Seems An Odd Short Target
For further details see:
Zynex receives FDA clearance for CM-1600 fluid monitor